Scynexis (SCYX) Convertible Debt (2019 - 2024)
Scynexis' (SCYX) quarterly Convertible Debt came in at $13.7 million in Q4 2024, up 12.58% YoY from $12.2 million in Q1 2024, and up 12.58% on a QoQ basis from $12.2 million in Q4 2023.
Scynexis (SCYX) Convertible Debt (2019 - 2024) Analysis & Trends
Scynexis (SCYX) has 6 years of Convertible Debt data on file, last reported at $13.7 million in Q4 2024.
- Quarterly Convertible Debt rose 12.58% year-over-year to $13.7 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $13.7 million (up 12.58% YoY) and the FY2024 annual result came in at $13.7 million, up 12.58% from the prior year.
- Convertible Debt grew to $13.7 million in Q4 2024, from $12.2 million in the prior quarter.
- In the past five years, Convertible Debt ranged from a high of $16.5 million in Q4 2020 to a low of $2.0 million in Q2 2020.
- A 5-year average of $11.4 million and a median of $11.6 million in 2021 frame the typical range for Convertible Debt.
- Annual changes were most pronounced in 2020 — Convertible Debt plunged 86.29% — and 2021, when it surged 499.8%.
- Tracing SCYX's Convertible Debt over 5 years: stood at $16.5 million in 2020, then declined by 29.72% to $11.6 million in 2021, then decreased by 5.22% to $11.0 million in 2022, then advanced by 10.53% to $12.2 million in 2023, then increased by 12.58% to $13.7 million in 2024.
- The last three Convertible Debt figures came in at $13.7 million (Q4 2024), $12.2 million (Q4 2023), and $11.8 million (Q3 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - |
| 10 | Scynexis | 61.37 Mn | -53.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 13.69 Mn |
| Dec 31, 2023 | 12.16 Mn |
| Sep 30, 2023 | 11.81 Mn |
| Jun 30, 2023 | 11.63 Mn |
| Mar 31, 2023 | 11.41 Mn |
| Dec 31, 2022 | 11.00 Mn |
| Sep 30, 2022 | 11.03 Mn |
| Jun 30, 2022 | 10.82 Mn |
| Mar 31, 2022 | 10.82 Mn |
| Dec 31, 2021 | 11.61 Mn |
| Sep 30, 2021 | 10.81 Mn |
| Jun 30, 2021 | 12.00 Mn |
| Mar 31, 2021 | 12.23 Mn |
| Dec 31, 2020 | 16.52 Mn |
| Sep 30, 2020 | 13.28 Mn |
| Jun 30, 2020 | 2.00 Mn |
| Mar 31, 2020 | 11.10 Mn |
| Dec 31, 2019 | 11.52 Mn |
| Sep 30, 2019 | 12.57 Mn |
| Jun 30, 2019 | 14.59 Mn |